806 Oncolytic adenovirus coding for human Mucin1 T cell engager with interleukin-2 potentiates anti-tumor T cell responses against tumors

• Akseli Hemminki,
• Anna Kanerva,
• João Manuel Santos,
• Saru Basnet,
• Santeri A Pakola,
• James Clubb,
• Elise Jirovec,
• Tatiana Kudling,
• Lyna Haybout,
• Mirte Van der Heijden,
• Susanna AM Grönberg-Vähä-Koskela,
• Victor Arias,
• Dafne Alves Quixabeira

Affiliations

Akseli Hemminki

3TILT Biotherapeutics, Helsinki, Finland

Anna Kanerva

5Department of Gynecology and Obstetrics, Helsinki University Hospital, Helsinki, Finland

João Manuel Santos

2Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland

Saru Basnet

1University of Helsinki, Helsinki, Finland

Santeri A Pakola

2Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland

James Clubb

2TILT Biotherapeutics Ltd., Helsinki, Finland

Elise Jirovec

2Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland

Tatiana Kudling

2Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland

Lyna Haybout

2Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland

Mirte Van der Heijden

2Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland

Susanna AM Grönberg-Vähä-Koskela

4Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland

Victor Arias

2Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland

Dafne Alves Quixabeira

2Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland